Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa
Clinical trial NCT02648126 · UNKNOWN
Trial details
- NCT number
- NCT02648126
- Sponsor
- The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2017-07-01
- Enrollment
- 531
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.